Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2024-517388-22-00 | EU Trial (CTIS) Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.
This is a Phase 2/3 multicenter, double-blind, placebo-controlled, three-arm, multicenter study evaluating the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia. The diagnosis of agitation will be based on the consensus definition for agitation in patients with cognitive disorders developed by te International Psychogeriatric Association (IPA) Agitation Definition Work Group as well as neuroimaging performed after onset of dementia symptoms and a Core 1 AD biomarker.
The study will be conducted at up to 60 centers in the US, Canada and Europe.. Screening will occur within approximately 4 weeks prior to randomization. Following screening procedures for assessment of inclusion and exclusion criteria, eligible participants will be randomized into the study. Approximately 100 patients per arm will be randomized (300 total).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EXV-802 | Experimental | Participants will be assigned to treatment with EXV-802 capsules administered twice a day over a 6-week period. |
|
| Placebo | Placebo Comparator | Participants will be assigned to treatment with placebo capsules administered twice a day over a 6-week period. |
|
| EXV-801 | Experimental | Participants will be assigned to treatment with EXV-801 capsules administered twice a day over a 6-week period. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EXV-802 | Drug | Specified dose twice daily |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes from baseline to endpoint (Week 6) in the Cohen-Mansfield Agitation Inventory - International Psychogeriatric Association (CMAI-IPA) score | The CMAI is used to assess the frequency of manifestations of agitated behaviors in elderly persons. It consists of 29 agitated behaviors that are further categorized into distinct agitation syndromes, also known as CMAI factors of agitation. These distinct agitation syndromes include aggressive behavior, physically nonaggressive behavior, and verbally agitated behavior. Each of the 29 items is rated on a 7-point scale of frequency (1 = never, 2 = less than once a week but still occurring, 3 = once or twice a week, 4 = several times a week, 5 = once or twice a day, 6 = several times a day, 7 = several times an hour). The ratings are based on the 2 weeks preceding assessment of the CMAI. Higher scores indicate higher frequency of agitated behaviors while lower scores indicate lower frequency of agitated behaviors The CMAI-IPA includes 19 items that were mapped to IPA agitation domains. The total score ranges from 19 to 133 with higher scores indicating more severity. | Baseline to Week 6 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes from baseline to endpoint (Week 6) in the Clinical Global Impression of Severity of Illness (CGI-S) score as related to symptoms of agitation | The CGI-S is an observer-rated scale that measures illness severity. The CGI-S is a 7-point (1-7) scale (1 = normal, not at all ill; 7 = extremely ill) that assessed the severity of agitation in this study. Higher scores indicate severe agitation, while the lower scores indicate little or no agitation. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes from baseline to endpoint (Week 6) in the Neuropsychiatric Inventory - Clinician (NPI-C) Caregiver Distress score for Agitation and Aggression domains | The NPI-C is a retrospective interview covering 14 neuropsychiatric symptom domains. The NPI-C version of the NPI scale was designed to be administered by the clinician to the participant and the caregiver. The caregiver is first asked to provide frequency, severity, and distress ratings for each individual item across the domains. Frequency is rated on a scale from 0 to 4. Severity is rated on a scale from 0 to 3. Separately, the rater interviews the patient to assess frequency (0 to 4) of each item. Clinician rating of clinical impression is a severity rating (0 to 3) based on all available clinical and interview information. For this endpoint, the caregiver distress will be analyzed for the agitation and aggression domains. Caregiver distress is rated on a scale from 0 to 5 with a total score range of 0 to 10 across the 2 domains. Higher scores indicate greater caregiver distress. |
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Exciva Clinical Studies | Contact | +49 6221-6479990 | studies@exciva.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Esperanza Clinical | Recruiting | Murrieta | California | 92562 | United States | |
| Josephson Wallack Munshower Neurology PC |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Specified dose twice daily |
|
| EXV-801 | Drug | Specified dose twice daily |
|
|
| Baseline to Week 6 |
| Baseline to Week 6 |
| Changes from baseline to endpoint (Week 6) in the Neuropsychiatric Inventory - Clinician (NPI-C) Irritability/Liability Domain score | The NPI-C is a retrospective interview covering 14 neuropsychiatric symptom domains. The NPI-C version of the NPI scale was designed to be administered by the clinician to the participant and the caregiver. The caregiver is first asked to provide frequency, severity, and distress ratings for each individual item across the domains. Frequency is rated on a scale from 0 to 4. Severity is rated on a scale from 0 to 3. Separately, the rater interviews the patient to assess frequency (0 to 4) of each item. Clinician rating of clinical impression is a severity rating (0 to 3) based on all available clinical and interview information. The score for the irritability/lability domain is the sum of clinical impression ratings of all items. There are 12 items in the irritability/lability domain. The minimum score for the irritability/lability domain is 0 and maximum score per domain is 36, with higher scores indicate greater symptom severity. | Baseline to Week 6 |
| Changes from baseline to endpoint (Week 6) in the Neuropsychiatric Inventory - Clinician (NPI-C) Sleep Disorders Domain score | The NPI-C is a retrospective interview covering 14 neuropsychiatric symptom domains. The NPI-C version of the NPI scale was designed to be administered by the clinician to the participant and the caregiver. The caregiver is first asked to provide frequency, severity, and distress ratings for each individual item across the domains. Frequency is rated on a scale from 0 to 4. Severity is rated on a scale from 0 to 3. Separately, the rater interviews the patient to assess frequency (0 to 4) of each item. Clinician rating of clinical impression is a severity rating (0 to 3) based on all available clinical and interview information. The score for the sleep disorders domain is the sum of clinical impression ratings of all items. There are 8 items in the sleep disorders domain. The minimum score for the sleep disorders domain is 0 and maximum score per domain is 24, with higher scores indicate greater symptom severity. | Baseline to Week 6 |
| Recruiting |
| Indianapolis |
| Indiana |
| 46260 |
| United States |
| Precise Research Centers | Recruiting | Flowood | Mississippi | 39232 | United States |
| Galen Research LLC | Not yet recruiting | Chesterfield | Missouri | 63005 | United States |
| Integrative Clinical Trials | Recruiting | Brooklyn | New York | 11229 | United States |
| Manhattan Behavioral Medicine | Recruiting | New York | New York | 10036 | United States |
| Insight Clinical Trials | Recruiting | Independence | Ohio | 44131 | United States |
| Oregon Health & Science University | Not yet recruiting | Portland | Oregon | 97239 | United States |
| The Memory Clinic | Recruiting | Bennington | Vermont | 05201 | United States |
| Sunnybrook Health Sciences Centre | Not yet recruiting | North York | Ontario | M4N 3M5 | Canada |
| Baycrest Centre for Geriatric Care | Not yet recruiting | North York | Ontario | M6A 2E1 | Canada |
| Kawartha Centre | Recruiting | Peterborough | Ontario | K9H 294 | Canada |
| Ontario Shores Centre for Mental Health Sciences | Not yet recruiting | Whitby | Ontario | L1N 5S9 | Canada |
| Brain-Soultherapy s.r.o. | Not yet recruiting | Kladno | Central Bohemia | 272 01 | Czechia |
| NeuropsychiatrieHK, sro | Not yet recruiting | Hradec Králové | Hradec Králové Region | 500 02 | Czechia |
| Psychiatrie-Ambulance s.r.o | Not yet recruiting | Pilsen | Plzeň Region | 301 00 | Czechia |
| FNUSA - St. Anne's University Hospital Brno | Not yet recruiting | Brno | South Moravian | 602 00 | Czechia |
| Medicum Gesundheitszentrum Flugfeld - Praxis Bischof & Secheres | Recruiting | Böblingen | Baden-Wurttemberg | 71034 | Germany |
| Curiositas ad sanum Studien und Beratungs GmbH | Not yet recruiting | Ebersberg | Bavaria | 85560 | Germany |
| TUM Klinikum rechts der Isar | Not yet recruiting | München | Bavaria | 81675 | Germany |
| Praxis Dr. med. Kirsten Hahn | Not yet recruiting | Berlin | State of Berlin | 13187 | Germany |
| Azienda Ospedaliera Universitaria Policlinico Tor Vergata | Not yet recruiting | Rome | Lazio | 00133 | Italy |
| Universita degli Studi di Roma ''La Sapienza" - Azienda Ospedaliera Sant'Andrea | Not yet recruiting | Rome | Lazio | 00189 | Italy |
| Azienda Ospedaliera Cardinale Giovanni Panico | Not yet recruiting | Tricase | Lecce | 73039 | Italy |
| IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli | Not yet recruiting | Brescia | Lombardy | 25125 | Italy |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Main Campus | Not yet recruiting | Milan | Lombardy | 20122 | Italy |
| Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone | Not yet recruiting | Palermo | Sicily | 90127 | Italy |
| Centrum Medyczne HCP Sp. z o.o. | Not yet recruiting | Poznan | Greater Poland Voivodeship | 61-485 | Poland |
| Krakowska Akademia Neurologii | Not yet recruiting | Krakow | Lesser Poland Voivodeship | 31-505 | Poland |
| NZOZ Wroclawskie Centrum Alzheimerowskie | Not yet recruiting | Wroclaw | Lower Silesian Voivodeship | 53-659 | Poland |
| FutureMeds Wroclaw | Not yet recruiting | Wroclaw | Lower Silesian Voivodeship | 53-673 | Poland |
| NZOZ Neuromed M. i M. Nastaj Spolka Partnerska | Not yet recruiting | Lublin | Lublin Voivodeship | 20-064 | Poland |
| RCMed Oddzial Sochaczew | Not yet recruiting | Sochaczew | Masovian Voivodeship | 69-500 | Poland |
| ETG Neuroscience Sp. z o.o. | Not yet recruiting | Warsaw | Masovian Voivodeship | 02-677 | Poland |
| Silmedic Sp. z o.o. | Recruiting | Katowice | Silesian Voivodeship | 40-282 | Poland |
| Clinhouse Sp. z o.o. | Not yet recruiting | Zabrze | Silesian Voivodeship | 41-807 | Poland |
| Velocity Clinical Research, Staszów | Recruiting | Staszów | Świętokrzyskie Voivodeship | 28-200 | Poland |
| MUDr. Beata Dupejova, Neurologicka Ambulancia S.r.o. | Not yet recruiting | Banská Bystrica | Banská Bystrica Region | 974 04 | Slovakia |
| Univerzitna nemocnica Bratislava | Not yet recruiting | Bratislava | Bratislava Kraj | 813 69 | Slovakia |
| EPAMED s r.o. | Not yet recruiting | Košice | Košice Region | 040 11 | Slovakia |
| Crystal Comfort S.R.O. | Not yet recruiting | Vranov nad Topľou | Presov | 093 01 | Slovakia |
| Medicinske Centrum Konzilium, s.r.o. | Not yet recruiting | Dubnica nad Váhom | Trenčín Region | 018 41 | Slovakia |
| Hospital Victoria Eugenia Cruz Roja Sevilla | Not yet recruiting | Seville | Andalusia | 41009 | Spain |
| Hospital Universitario Rio Hortega | Not yet recruiting | Valladolid | Castille and León | 47012 | Spain |
| Hospital Virgen de la Concha | Not yet recruiting | Zamora | Castille and León | 49029 | Spain |
| Hospital Universitari Germans Trias i Pujol | Not yet recruiting | Barcelona | Catalonia | 08916 | Spain |
| Hospital Clinico San Carlos | Recruiting | Madrid | 28040 | Spain |
| Scottish Brain Sciences | Recruiting | Edinburgh | Midlothian | EH12 5PJ | United Kingdom |
| Scottish Brain Sciences | Recruiting | Aberdeen | North East Scotland | AB25 2XE | United Kingdom |
| ID | Term |
|---|---|
| D003915 | Dextromethorphan |
| C060555 | deramciclane |
| ID | Term |
|---|---|
| D009019 | Morphinans |
| D053610 | Opiate Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |
Not provided
Not provided